(βR)-6-Bromo-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol

Catalog No. :
ACGTBR726
CAS No. :
1298044-24-2
Molecular Formula :
C28H22BrNO2
Molecular Weight :
484.39

IUPAC Name:(2R)-2-(6-bromo-2-methoxyquinolin-3-yl)-1-(naphthalen-1-yl)-2-phenylethan-1-ol

(βR)-6-Bromo-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$1939.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(βR)-6-Bromo-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol
IUPAC Name(2R)-2-(6-bromo-2-methoxyquinolin-3-yl)-1-(naphthalen-1-yl)-2-phenylethan-1-ol
MDL No.0
Molecular FormulaC28H22BrNO2
Molecular Weight484.39
SMILESCOC1=NC2=CC=C(Br)C=C2C=C1[C@@H](C1=CC=CC=C1)C(O)C1=CC=CC2=CC=CC=C12
InChI KeyBDFILYYATTXFLA-AVJYQCBHSA-N
Synonym3-Quinolineethanol, 6-bromo-2-methoxy-α-1-naphthalenyl-β-phenyl-, (βR)-;(βR)-6-Bromo-2-methoxy-α-1-naphthalenyl-β-phenyl-3-quinolineethanol;2-(6-bromo-2-methoxyquinolin-3-yl)-1-(naphthalen-1-yl)-2-phenylethanol
CAS No.1298044-24-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGTBR726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGTBR726 route product structure diagram
    ACGTBR7261298044-24-2 In Stock
Inquiry

2. ACGTBR726 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGTBR726 route product structure diagram
    ACGTBR7261298044-24-2 In Stock
Inquiry

Comments (0)